EUVIMEDAvasta EUVIMED
Randomisierte kontrollierte StudieMultizentrische StudieOpen access

Mobile App for Gynecologic Cancer Support for Patients With Gynecologic Cancer Receiving Chemotherapy in China: Multicenter Randomized Controlled Trial

Huicong Lin iD, Mingzhu Ye iD, Yanjuan Lin iD, Fuhong Chen iD, Sally Chan iD, Hongxia Cai iD, Jiemin Zhu iD

Journal of Medical Internet Research · 2023

DOI: 10.2196/49939 ↗

At a glance

Randomisierte kontrollierte Studie in Journal of Medical Internet Research, 2023. Written by Huicong Lin and 6 co-authors. Institution: School of Medicine, Xiamen University, Xiamen, Fujian Province, China. Major MEDLINE topics: Genital Neoplasms, Female, Mobile Applications. Cited 11 times so far (Crossref); 53 references. The full text is freely available in PubMed Central.

AbstraktSubjectsBibliograafilised andmedCiteRelated studies

Abstract (original language)

Background

Patients with gynecologic cancer receiving chemotherapy often report unmet supportive care needs. Compared with traditional face-to-face clinical interventions, mobile health can increase access to supportive care and may address patients’ needs. Although app-based support programs have been developed to support patients with gynecologic cancer, their efficacy has not been adequately tested.

Objective

The aim of this study was to examine the efficacy of a mobile app for gynecologic cancer support (MGCS) for patients with gynecologic cancer receiving chemotherapy in China.

Methods

A multicenter randomized controlled trial was conducted in 2 university-affiliated hospitals in China. A total of 168 Chinese patients with gynecologic cancer were recruited and randomized to receive routine care or MGCS program plus routine care for 24 weeks. The Mishel uncertainty in illness theory guided the development of MGCS program, which has 4 modules: weekly topics, emotional care, discussion center, and health consultation. The primary outcome of this program was the assessment of the uncertainty in illness. The secondary outcomes were quality of life, symptom distress, and social support. All health outcomes were evaluated at baseline (T0), 12 weeks (T1), and 24 weeks (T2). Repeated measures analysis of covariance was used to assess the efficacy of the MGCS program.

Results

In this trial, 67 patients in the control group and 69 patients in the intervention group completed 2 follow-up assessments (response rate, 136/168, 81%). At 12 weeks, no significant differences were observed in any of the health outcomes between the 2 groups. At 24 weeks, compared to patients in the control group, those in the intervention group reported significant decreased uncertainty in illness (P

Subjects

MeSH terms (MEDLINE)

Genital Neoplasms, FemaleMobile ApplicationsFemaleHumansChinaQuality of LifeSocial Support

Author keywords

applicationcancercancer carechemotherapyemotional well-beinggynecologicgynecologic cancermobile appmobile phonequality of lifesocial supportsupportsymptom distressuncertainty in illnesswell-being

Authors and institutions

  • School of Medicine, Xiamen University, Xiamen, Fujian Province, China.
  • Women and Children's Hospital, School of Medicine, Xiamen University, Xiamen, Fujian Province, China.
  • Department of Gynecology and Obstetrics, Zhongshan Hospital, Xiamen University, Xiamen, Fujian Province, China.
  • Department of Nursing, Fujian Medical University Union Hospital, Fuzhou, Fujian Province, China.
  • Department of Nursing, First Affiliated Hospital, Xiamen University, Xiamen, Fujian Province, China.
  • President Office, Tung Wah College, Hongkong, China.

ORCID profiles: Huicong Lin, Mingzhu Ye, Yanjuan Lin, Fuhong Chen, Sally Chan, Hongxia Cai, Jiemin Zhu

Cite

APA

Lin, H., Ye, M., Lin, Y., Chen, F., Chan, S., Cai, H., & Zhu, J. (2023). Mobile App for Gynecologic Cancer Support for Patients With Gynecologic Cancer Receiving Chemotherapy in China: Multicenter Randomized Controlled Trial. Journal of Medical Internet Research. https://doi.org/10.2196/49939

Vancouver

Lin H, Ye M, Lin Y, Chen F, Chan S, Cai H, et al. Mobile App for Gynecologic Cancer Support for Patients With Gynecologic Cancer Receiving Chemotherapy in China: Multicenter Randomized Controlled Trial. Journal of Medical Internet Research. 2023. doi:10.2196/49939

BibTeX
@article{Lin2023,
  author = {Lin, Huicong and Ye, Mingzhu and Lin, Yanjuan and Chen, Fuhong and Chan, Sally and Cai, Hongxia and Zhu, Jiemin},
  title = {Mobile App for Gynecologic Cancer Support for Patients With Gynecologic Cancer Receiving Chemotherapy in China: Multicenter Randomized Controlled Trial},
  journal = {Journal of Medical Internet Research},
  year = {2023},
  doi = {10.2196/49939}
}
Start for free →